Literature DB >> 7508492

Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission.

T T Chang1, T C Liou, K C Young, X Z Lin, C Y Lin, J S Shin, H L Wu.   

Abstract

To evaluate the intrafamilial transmission of hepatitis C virus (HCV) 104 index patients with type C chronic liver disease and their 307 family contacts were interviewed. After a questionnaire on the risk factors of parenteral exposure, blood samples were obtained and tested for liver biochemistry and anti-HCV antibody by enzyme-linked immunosorbent assay (Abbott II). Overall, 52 family contacts (17%) were positive for anti-HCV, indicating a higher anti-HCV prevalence among family contacts than among the general population in Taiwan. The anti-HCV prevalences in parents, spouses, children, and other contacts of the patients were 54% (14/26), 28% (25/91), 6.9% (10/143), and 6.4% (3/47), respectively. The contacts of index patients had increasingly greater risk of HCV infection when they became older and had lived longer with index patients. All family contacts were divided into two groups categorized by whether the index patients had or did not have a history of parenteral exposure. Among 126 family contacts of the 42 patients without parenteral exposure, blood transfusion and surgery were the factors significantly associated with HCV infection in these family contacts (odds ratio = 7.26, 95% confidence interval = 2.32-32.67; odds ratio = 3.95, 95% CI = 1.29-12.11, respectively). Risk factors were not significantly associated with HCV infection among 181 family contacts of the 62 index patients with parenteral exposure. It is concluded that the index patients without parenteral exposure appeared to have acquired the disease from HCV-infected family members with risk factors. Most of the index patients had a history of parenteral exposure and in turn served as the source of the disease for family members.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508492     DOI: 10.1002/jmv.1890420117

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  HCV transmission in family members of subjects with HCV related chronic liver disease.

Authors:  L Demelia; E Vallebona; R Poma; G Sanna; G Masia; R C Coppola
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 2.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 3.  Sexual transmission of hepatitis C virus infection.

Authors:  G Rooney; R J Gilson
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

4.  Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study.

Authors:  E Sagnelli; G B Gaeta; F M Felaco; T Stroffolini; S Conti; A Glielmo; F Piccinino; G Giusti
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

5.  Epidemiology of hepatitis C virus infection in a tertiary care hospital.

Authors:  Atul Kumar Sood; Manish Manrai; Sandeep Thareja; Rajat Shukla; Amol Patel
Journal:  Med J Armed Forces India       Date:  2019-12-11

Review 6.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 7.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 8.  Hepatitis in nursing homes. Incidence and management strategies.

Authors:  A Floreani; M Chiaramonte
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

9.  A cross sectional study of the risk factors of hepatitis C infection in North Egypt.

Authors:  Soad S Mandoh; Kholoud Ayman; Ahmed Elbardakheny; Hala Raaft; Ahmed A Ibrahim; Rasha Alsaeed Alshaikh; Fotouh R Mansour
Journal:  Virusdisease       Date:  2021-03-20

10.  Anti-HCV prevalence in the general population of Lithuania.

Authors:  Valentina Liakina; Jonas Valantinas
Journal:  Med Sci Monit       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.